Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001415889-25-004251·Century Therapeutics, Inc.
Schedule 13G ownership disclosure
Century Therapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 15673T100
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners III, L.P.
Shares: 3,957,186.00 · Class: 4.7%
- VHCP Co-Investment Holdings III, LLC
Shares: 3,957,186.00 · Class: 4.7%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 3,957,186.00 · Class: 4.7%
- VHCP Management III, LLC
Shares: 3,957,186.00 · Class: 4.7%
- VHCP Management EG, LLC
Shares: 3,957,186.00 · Class: 4.7%
- Nimish Shah
Shares: 3,957,186.00 · Class: 4.7%
- Bong Y Koh
Shares: 3,957,186.00 · Class: 4.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-004251
- Form type
- SCHEDULE 13G/A
- Filer
- Century Therapeutics, Inc.
- CIK
- CIK 1850119
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership